Regulatory News
Wednesday, July 20, 2016
Mylan gets EU approval for Meda purchase, subject to conditions
BRUSSELS, July 20 (Reuters) - EU antitrust regulators said
on Wednesday they had cleared generic drugmaker Mylan's
planned cash-and-stock purchase of Sweden's Meda
subject to it selling certain...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment